Adverse neurologic events of immune checkpoint inhibitor monotherapy vs. combination therapy for melanoma is a research paper published in Neuro-Oncology Advances (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UM1TR004528
National Institutes of Health
Grant: 5UM1TR004528-03
Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages for Everyone's Health (CLE Health)
FWCI
1.45
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals